Source: International Congress 2016 – ILD: from the bench to the bedside
Disease area: Interstitial lung diseases, Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Katerina Antoniou (Heraklion, Crete, Greece), Stylianos Michelakis, Eliza Tsitoura, Izoldi Bouloukaki, Violeta Moniaki, Niki Malliaraki, Giorgos Papadogiannis, Stavroula Varda, Dimitrios Georgopoulos, Nikos Tzanakis, Sophia E. Schiza, Katerina Antoniou. Investigation of KL-6 levels in patients with IPF- OSA overlap syndrome: Preliminary results. Eur Respir J 2016; 48: Suppl. 60, 3901

Member's Comments

No comment yet.

Related content which might interest you: Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Serum midkine levels in patients with obstructive sleep apnea Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015 Serum KL-6 as a multidimensional biomarker in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 MMP7-degraded elastin is elevated in serum of patients with idiopathic pulmonary fibrosis Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 Effectiveness of Home­based Pulmonary Rehabilitation for COPD patients with OSA: overlap syndrome. Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 Association of obstructive sleep apnea syndrome and idiopathic pulmonary fibrosis: in vitro and in vivo study based on physical characteristics Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 The association between hypertension and neutrophil to lymphocyte ratio in patients with obstructive sleep apnea syndrome Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016 Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases Source: International Congress 2014 – Sleep disordered breathing 3 Year: 2014 Onset of symptoms in idiopathic pulmonary fibrosis: A case-control study Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Familial cases of idiopathic pulmonary fibrosis: Clinical observation Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 Sleep quality among patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Clinical significance of autoantibody screening in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF treatment II Year: 2016 Blood pressure indices in patients with obstructive sleep apnea and overlap syndrome Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014 Self-reported sleep quality in IPF Source: International Congress 2014 – ILDs 5 Year: 2014 Prognostic significance of selected biomarkers in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease Source: International Congress 2014 – Sarcoidosis Year: 2014 Validation of GAP score in Danish patients diagnosed with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Prevalence of obstructive sleep apneas in patients with idiopathic interstitial pneumonia Source: International Congress 2015 – IIPs: orphan Year: 2015 LATE-BREAKING ABSTRACT: The level of markers of endothelial dysfunction in men with chronic obstructive pulmonary disease and osteopenic syndrome Source: International Congress 2014 – COPD markers Year: 2014 Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014